X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16626) 16626
Book Review (2097) 2097
Publication (602) 602
Conference Proceeding (167) 167
Book Chapter (62) 62
Magazine Article (29) 29
Book / eBook (22) 22
Dissertation (16) 16
Newsletter (10) 10
Web Resource (10) 10
Journal / eJournal (2) 2
Newspaper Article (2) 2
Reference (2) 2
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11636) 11636
index medicus (11566) 11566
essential-hypertension (8926) 8926
male (7886) 7886
essential hypertension (7165) 7165
female (6831) 6831
middle aged (5963) 5963
adult (5133) 5133
peripheral vascular disease (4216) 4216
hypertension (3873) 3873
blood pressure (3411) 3411
aged (3237) 3237
blood-pressure (3217) 3217
hypertension - physiopathology (2555) 2555
risk factors (2128) 2128
hypertension - drug therapy (1882) 1882
cardiac & cardiovascular systems (1816) 1816
blood pressure - drug effects (1749) 1749
animals (1685) 1685
pharmacology & pharmacy (1662) 1662
blood pressure - physiology (1320) 1320
disease (1138) 1138
hypertension - blood (1102) 1102
hypertension - genetics (1061) 1061
medicine, general & internal (1057) 1057
abridged index medicus (1019) 1019
antihypertensive agents - therapeutic use (1006) 1006
rats (998) 998
old medline (973) 973
adolescent (969) 969
hypertension - complications (963) 963
association (959) 959
risk (941) 941
urology & nephrology (909) 909
genotype (907) 907
endocrinology & metabolism (832) 832
myocardial-infarction (817) 817
case-control studies (777) 777
medicine, research & experimental (764) 764
atherosclerosis (762) 762
mortality (752) 752
physiology (730) 730
echocardiography (717) 717
polymorphism, genetic (716) 716
research (700) 700
insulin resistance (695) 695
cardiovascular-disease (693) 693
obesity (667) 667
health aspects (659) 659
prevalence (643) 643
polymorphism (640) 640
population (639) 639
hypertrophy (629) 629
aged, 80 and over (620) 620
left-ventricular hypertrophy (617) 617
hypertension - etiology (601) 601
double-blind method (598) 598
body mass index (596) 596
hypertension - metabolism (592) 592
physiological aspects (576) 576
renin - blood (567) 567
cross-sectional studies (563) 563
time factors (558) 558
analysis (557) 557
cardiovascular system (556) 556
prospective studies (554) 554
treatment outcome (551) 551
blood pressure monitoring, ambulatory (543) 543
nitric-oxide (535) 535
cardiovascular disease (529) 529
sodium (529) 529
insulin-resistance (528) 528
nitric oxide (525) 525
left ventricular hypertrophy (520) 520
endothelium (519) 519
oxidative stress (514) 514
renin-angiotensin system (511) 511
biochemistry & molecular biology (506) 506
risk-factors (505) 505
follow-up studies (498) 498
hemodynamics (494) 494
metabolic syndrome (492) 492
genetic aspects (488) 488
genetics (485) 485
hypertension - epidemiology (483) 483
aldosterone (482) 482
reference values (474) 474
heart rate (465) 465
genetic predisposition to disease (464) 464
heart rate - drug effects (461) 461
alleles (454) 454
heart-failure (454) 454
endothelial dysfunction (450) 450
medicine & public health (450) 450
angiotensin-ii (448) 448
prognosis (448) 448
angiotensin-converting enzyme inhibitors - therapeutic use (443) 443
hypertension - diagnosis (441) 441
polymorphism, single nucleotide (432) 432
regression analysis (432) 432
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15554) 15554
German (335) 335
Russian (265) 265
Spanish (171) 171
French (121) 121
Italian (75) 75
Chinese (71) 71
Polish (64) 64
Japanese (56) 56
Portuguese (38) 38
Korean (27) 27
Czech (14) 14
Turkish (13) 13
Dutch (8) 8
Ukrainian (7) 7
Swedish (6) 6
Danish (4) 4
Persian (4) 4
Romanian (4) 4
Slovak (4) 4
Hungarian (3) 3
Indonesian (2) 2
Norwegian (2) 2
Hebrew (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


09/2013
There is an ongoing debate on the role of serum uric acid as an independent risk factor for hypertension and renal disease. This study determined the serum... 
Essential hypertension | Hyperuricaemia | Nigeria
Web Resource
Web Resource
Plasma Lipoprotein (a) levels in patients with untreated essential hypertension, 07/2003
Lipoprotein (a) [Lp (a)] is considered as a risk factor for vascular diseases, especially those associated with renal failure. Adequate studies have not been... 
Genetics | hg03013 Essential hypertension, Lipids, Lipoprotein (a)
Journal
10/2011
Objectives: To study the effect of nebivolol 5 mg once daily versus (S)-atenolol 25 mg once daily in patients with essential hypertension. Materials and... 
Essential hypertension | nebivolol | (S)-atenolol
Web Resource
1989, ISBN 9783794512782, ix, 151
Book
12/2010
Background: Essential hypertension is a complex genetic trait. Genetic variant of alpha adducin (ADD1) gene have been implicated as a risk factor for... 
Essential hypertension | South Indians | polymorphism | ADD1
Web Resource
07/2007
Background : Although a wide number of experimental evidences are available regarding oxidant-antioxidant disturbance in hypertension, clinical data supporting... 
Antioxidants | essential hypertension | oxidative stress
Web Resource
01/2010
In this study 250 patients with essential hypertension were investigated in comparison to 218 normotensives for association with epidemiological parameters. Of... 
Essential hypertension | polymorphism | endothelial NOS gene
Web Resource
10/2009
Background: Telmisartan provides effective treatment of hypertension in a broad spectrum of patients. Aims: To evaluate factors affecting the efficacy of... 
predictors | telmisartan | Daily practice | essential hypertension
Web Resource
Clinical and Experimental Hypertension, ISSN 1064-1963, 11/2019, Volume 41, Issue 8, pp. 779 - 786
Background and Objectives: Essential hypertension is a complex progressive cardiovascular disorder. Renin-angiotensin aldosterone system (RAAS) plays a major... 
Essential hypertension | ARR | polymorphism | CYP11B2 | aldosterone
Journal Article
Original Communication - Family based analysis of quantitative changes of erythrocyte membrane proteins in essential hypertension, 12/2004
Our previous studies have found significant quantitative changes in the erythrocyte membrane proteins in essential hypertension (EH). The purpose of the... 
Essential hypertension, genetic contribution, major gene effect, pleiotropy, erythrocyte membrane proteins, anion exchanger, glucose transporter, cytoskeletal proteins, quantitative variation
Journal
Medičnì Perspektivi, ISSN 2307-0404, 09/2016, Volume 21, Issue 3, pp. 26 - 29
In 41 patients with essential hy­pertension I and II degrees telmisartan influence on parameters of intimate heodynamics and functional condition of myocardium... 
telmisartan | essential hypertension | hemodynamics
Journal Article
02/2012
Background : The vitamin D receptor (VDR) gene serves as a good candidate gene for susceptibility to several diseases. The gene has a critical role in... 
Essential hypertension | risk prediction | vitamin D | VDR gene Fok I polymorphism
Web Resource
Arterial Hypertension (Russian Federation), ISSN 1607-419X, 2018, Volume 24, Issue 2, pp. 217 - 222
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.